RxDoctor Payments Data

Zubeen Mistry, DPM

Foot Surgery · Plano, TXNPI 1023467586

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,175 and has fallen 84.7% since, to $180 in 2025.

$5,666in general payments, 2019–2025

Across 170 payments — averaging $33.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • Stryker$1K
  • Smith+Nephew$698
  • Sanara Medtech Inc.$685
  • Integra Lifesciences Corporation$297
  • Johnson & Johnson$195
  • plus $1K from 25 others

What the payments were for

  • Travel & lodging$100%
  • Food & beverage$5,657100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,666 in reported general payments places this provider in the 65th percentile of 71 foot surgery providers in Texas.

See all foot surgery providers in Texas

Medicare billing

Part B allowed, 2024
$722,211
Medicare patients
302
Services billed
2,205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox20$654
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip20$565
Clindamycin Hcl14$140
Cephalexin26$115
Methylprednisolone14$100
Gabapentin16$98
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$84
Meloxicam39$58

Paid to pharmacies, not to this prescriber.

Other foot surgery in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →